Theresa Lowry
Human Resources Officer at ZURA BIO LIMITED
Profile
Theresa Lowry is currently the Chief Human Resources Officer at Zura Bio Ltd.
Prior to this, she held positions as Senior Director-Human Resources Operations at ResMed, Inc., Director-HR, Global Total Rewards & HRIS at Encore Capital Group, Inc., and Head-Global HR Operations & Total Rewards at Arena Pharmaceuticals, Inc. She also served as Head-Global HR Operations & Total Rewards at ACADIA Pharmaceuticals, Inc. from 2019 to 2020 and as Head-Global Rewards & HR Operations at Ultragenyx Pharmaceutical, Inc. She is currently the VP-Human Resources & Business Operations at Metacrine, Inc. from 2020 to 2023.
Ms. Lowry received her undergraduate degree from the University of Virginia and her graduate degree from the University of San Diego School of Law.
Theresa Lowry active positions
Companies | Position | Start |
---|---|---|
ZURA BIO LIMITED | Human Resources Officer | - |
Former positions of Theresa Lowry
Companies | Position | End |
---|---|---|
METACRINE, INC. | Human Resources Officer | 2023-02-28 |
ACADIA PHARMACEUTICALS INC. | Human Resources Officer | 2020-07-31 |
ARENA PHARMACEUTICALS | Human Resources Officer | - |
ENCORE CAPITAL GROUP, INC. | Human Resources Officer | - |
RESMED, INC. | Human Resources Officer | - |
Training of Theresa Lowry
University of San Diego School of Law | Graduate Degree |
University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 6 |
---|---|
METACRINE, INC. | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
RESMED, INC. | Health Technology |
ENCORE CAPITAL GROUP, INC. | Finance |
ZURA BIO LIMITED | Health Technology |
Private companies | 1 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Stock Market
- Insiders
- Theresa Lowry